NCT06991738 2026-04-17
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Not yet recruiting
Clinical Trials
11 trialsNCT07536412 2026-04-17
Decision Aid Efficacy in Low Risk Thyroid Cancer
University of Maryland, Baltimore
Phase NA Not yet recruiting
NCT07485569 2026-04-15
REPOTHYROID-II
Radboud University Medical Center
Phase 1 Not yet recruiting
NCT07532356 2026-04-15
Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
National Taiwan University Hospital
Not yet recruiting
NCT07225309 2026-04-14
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Not yet recruiting
NCT07524777 2026-04-13
Ganoderma Spores Modulate the Gut-Brain Axis
Zhejiang Cancer Hospital
Phase NA Not yet recruiting
NCT07459283 2026-03-10
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07193186 2026-02-27
Anlotinib and Benmelstobart in DTC
Fudan University
Phase 2 Not yet recruiting
NCT07406087 2026-02-25
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Phase NA Not yet recruiting
NCT07405320 2026-02-12
A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
University of Auckland, New Zealand
Phase NA Not yet recruiting
NCT06647602 2026-02-10
THRIVE
University Medical Center Groningen
Not yet recruiting